These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7266467)

  • 1. Human dopamine-beta-hydroxylase: comparison of the enzyme from plasma, adrenal medulla, and pheochromocytoma by radioimmunoassay.
    Frigon RP; O'Connor DT; Levine GL
    Mol Pharmacol; 1981 May; 19(3):444-50. PubMed ID: 7266467
    [No Abstract]   [Full Text] [Related]  

  • 2. Human pheochromocytoma dopamine-beta-hydroxylase: purification and molecular parameters of the tetramer.
    O'Connor DT; Frigon RP; Stone RA
    Mol Pharmacol; 1979 Sep; 16(2):529-38. PubMed ID: 514256
    [No Abstract]   [Full Text] [Related]  

  • 3. Dopamine-beta-hydroxylase: structural comparisons of membrane-bound versus soluble forms from adrenal medulla and pheochromocytoma.
    Sokoloff RL; Frigon RP; O'Connor DT
    J Neurochem; 1985 Feb; 44(2):411-20. PubMed ID: 3965617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of dopamine beta-hydroxylase activity in normal rat adrenal medulla and rat pheochromocytoma cells.
    Wong DL; Ciaranello RD
    Brain Res; 1985 Dec; 358(1-2):144-9. PubMed ID: 4075111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine hydroxylase in human adrenal and pheochromocytoma: localization, kinetics, and catecholamine inhibition.
    Waymire JC; Weiner N; Schneider FH; Goldstein M; Freedman LS
    J Clin Invest; 1972 Jul; 51(7):1798-804. PubMed ID: 4402349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proceedings: Serum dopamine beta hydroxylase activity in various diseases].
    Hara I; Itatsu T; Kojima T; Suzuki S; Mizuno M
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):641. PubMed ID: 4476634
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dopamine -beta-hydroxylase].
    Isobe K
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():419-21. PubMed ID: 20960808
    [No Abstract]   [Full Text] [Related]  

  • 8. [Catecholamines, their enzymes and renin activity in the blood of patients with pheochromocytoma].
    Langosh I; Novotny I; Blazhichek R; Kvetianski R; Burdiga A
    Sov Med; 1977 Jun; (6):75-7. PubMed ID: 561444
    [No Abstract]   [Full Text] [Related]  

  • 9. [Plasma dopamine-beta-hydroxylase activity in pheochromocytoma (author's transl)].
    Guilland JC; Caillard B; Putelat R; Klepping C; Klepping J; Malval M
    Ann Endocrinol (Paris); 1980; 41(1):43-9. PubMed ID: 7396393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine β-hydroxylase: An Essential and Optimal Immunohistochemical Marker for Pheochromocytoma and Sympathetic Paraganglioma.
    Kimura N
    Endocr Pathol; 2021 Jun; 32(2):258-261. PubMed ID: 33405069
    [No Abstract]   [Full Text] [Related]  

  • 11. Tyrosine hydroxylase:--examination of conditions influencing activity in pheochromocytoma, adrenal medulla and striatum.
    Hegstrand LR; Simon JR; Roth RH
    Biochem Pharmacol; 1979; 28(4):519-23. PubMed ID: 34406
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative study of plasma dopamine-beta-hydroxylase activities in noradrenaline-secreting and adrenaline-secreting phaeochromocytomae.
    Aunis D; Bouclier M
    Clin Exp Pharmacol Physiol; 1977; 4(4):359-63. PubMed ID: 908179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of serum dopamine-beta hydroxylase analysis in endocrine tests of the adrenal medulla and sympathetic nervous system].
    Morii N; Nakao K; Shimbo S
    Nihon Rinsho; 1989 Dec; 48 Suppl():1174-7. PubMed ID: 2621840
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism of biosynthesis of soluble and membrane-bound forms of dopamine beta-hydroxylase in PC12 pheochromocytoma cells.
    Sabban EL; Greene LA; Goldstein M
    J Biol Chem; 1983 Jun; 258(12):7812-8. PubMed ID: 6863265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and immunochemical characterization of dopamine beta-hydroxylase from human pheochromocytoma.
    Park DH; Kashimoto T; Ebstein RP; Goldstein M
    Mol Pharmacol; 1976 Jan; 12(1):73-81. PubMed ID: 943692
    [No Abstract]   [Full Text] [Related]  

  • 16. Purification and characterization of rat pheochromocytoma dopamine beta-hydroxylase.
    Fong JC; Shenkman L; Goldstein M
    J Neurochem; 1980 Feb; 34(2):346-50. PubMed ID: 7411149
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the interaction of dopamine beta-hydroxylase from various sources with phytohaemagglutinins.
    Miras MT; Aunis D; Mandel P
    Clin Chim Acta; 1975 Nov; 64(3):293-302. PubMed ID: 1183043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal regulation of catecholamine synthesis in pheochromocytoma.
    Roth RH; Stjärne L; Levine RJ; Giarman NJ
    J Lab Clin Med; 1968 Sep; 72(3):397-403. PubMed ID: 5674070
    [No Abstract]   [Full Text] [Related]  

  • 19. Intracellular localization of tyrosine hydroxylase immunoreactivity in the rat adrenal chromaffin and pheochromocytoma cells.
    Oomori Y; Okuno S; Fujisawa H; Satoh T; Ono K
    Acta Anat (Basel); 1989; 136(1):1-8. PubMed ID: 2573225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dopamine-beta-hydroxylase].
    Isobe K; Nakai T
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():391-4. PubMed ID: 16149537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.